Menu
OR
MSN logo
OR
Late Sodium Channel Inhibitors in CCS Management

Cardiology - Clinical Cardiology

loading

This infographic summarizes the 2024 ESC Guidelines on the contemporary management of chronic coronary syndrome (CCS), highlighting a patient-centred approach to antianginal therapy. It explains the role of late sodium channel inhibitors, such as ranolazine, in patients with persistent angina despite first-line treatment. The infographic outlines individualized treatment strategies based on heart rate, blood pressure, left ventricular function, comorbidities, and patient preferences, emphasizing optimized symptom control, improved quality of life, and better treatment adherence through tailored therapy.


0 Likes

0 Comments


Profile
Coronary Connect

As the management of chronic angina continues to evolve, understanding the clinical value of novel therapeutic approaches has become increasingly important. Coronary Connect is a scientific forum dedicated to fostering clinical learning through evolving treatment strategies, practical insights, and meaningful scientific exchange, empowering healthcare professionals to deliver personalized, evidence-based care and improve patient outcomes.

© 2026 i-rhythm, All Rights Reserved. MSN i-Rhythm does not provide medical advice, diagnosis or treatment.

Sustain the Knowledge Stream!

For unrestricted access to content and a seamless experience,

Continue to Login

Don't have an account?

We’d love to get to know you better!

Complete your profile to help us deliver a more personalized experience.